Cardiol Therapeutics Management
Management criteria checks 2/4
Cardiol Therapeutics' CEO is David Elsley, appointed in Jan 2017, has a tenure of 7.5 years. total yearly compensation is CA$748.10K, comprised of 70.2% salary and 29.8% bonuses, including company stock and options. directly owns 1.76% of the company’s shares, worth $2.41M. The average tenure of the management team and the board of directors is 4.8 years and 2.5 years respectively.
Key information
David Elsley
Chief executive officer
CA$748.1k
Total compensation
CEO salary percentage | 70.2% |
CEO tenure | 7.5yrs |
CEO ownership | 1.8% |
Management average tenure | 4.8yrs |
Board average tenure | 2.5yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Mar 31 2024 | n/a | n/a | -CA$30m |
Dec 31 2023 | CA$748k | CA$525k | -CA$28m |
Sep 30 2023 | n/a | n/a | -CA$28m |
Jun 30 2023 | n/a | n/a | -CA$30m |
Mar 31 2023 | n/a | n/a | -CA$29m |
Dec 31 2022 | CA$654k | CA$525k | -CA$31m |
Sep 30 2022 | n/a | n/a | -CA$30m |
Jun 30 2022 | n/a | n/a | -CA$32m |
Mar 31 2022 | n/a | n/a | -CA$32m |
Dec 31 2021 | CA$1m | CA$455k | -CA$32m |
Sep 30 2021 | n/a | n/a | -CA$35m |
Jun 30 2021 | n/a | n/a | -CA$30m |
Mar 31 2021 | n/a | n/a | -CA$27m |
Dec 31 2020 | CA$517k | CA$450k | -CA$21m |
Sep 30 2020 | n/a | n/a | -CA$14m |
Jun 30 2020 | n/a | n/a | -CA$13m |
Mar 31 2020 | n/a | n/a | -CA$13m |
Dec 31 2019 | CA$450k | CA$450k | -CA$14m |
Sep 30 2019 | n/a | n/a | -CA$20m |
Jun 30 2019 | n/a | n/a | -CA$21m |
Mar 31 2019 | n/a | n/a | -CA$19m |
Dec 31 2018 | CA$713k | CA$363k | -CA$16m |
Compensation vs Market: David's total compensation ($USD547.23K) is about average for companies of similar size in the US market ($USD697.54K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Elsley
7.5yrs
Tenure
CA$748,100
Compensation
Mr. David G. Elsley, MBA, has been the President, Chief Executive Officer and Director of Cardiol Therapeutics Inc since January 19, 2017. Mr. Elsley is a business leader with a proven track record of deve...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7.5yrs | CA$748.10k | 1.76% CA$ 2.4m | |
CFO, Corporate Secretary & Director | 5.9yrs | CA$294.80k | 0.16% CA$ 219.7k | |
Chief Operating Officer | 3.6yrs | CA$515.90k | 0.044% CA$ 59.9k | |
Chief Medical Officer & Head of Research & Development | 3.3yrs | CA$746.56k | 0.35% CA$ 478.0k | |
Investor Relations | no data | no data | no data |
4.8yrs
Average Tenure
Experienced Management: CRDL's management team is considered experienced (4.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 7.5yrs | CA$748.10k | 1.76% CA$ 2.4m | |
CFO, Corporate Secretary & Director | 2.2yrs | CA$294.80k | 0.16% CA$ 219.7k | |
Independent Director | 4.6yrs | CA$60.00k | 0.21% CA$ 284.6k | |
Independent Director | 2.3yrs | CA$76.92k | 0% CA$ 0 | |
Independent Director | 6.6yrs | CA$58.00k | 0.68% CA$ 933.2k | |
Independent Director | 2.8yrs | CA$71.52k | 1.13% CA$ 1.5m | |
Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
Member of Scientific Advisory Board | 2.5yrs | no data | no data | |
Independent Director | 2.2yrs | CA$82.32k | 0.088% CA$ 119.8k | |
Independent Chairman | 5.9yrs | CA$112.68k | 0.22% CA$ 304.3k | |
Member of Scientific Advisory Board | 2.5yrs | no data | no data |
2.5yrs
Average Tenure
56yo
Average Age
Experienced Board: CRDL's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.